Latest updates for Colossal Biosciences

Fresh curated links around Colossal Biosciences are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
  • How Colossal is incubating an empire of startups
  • 10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

techcrunch.com /1 month ago

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Read source
fastcompany.com /2 weeks ago

How Colossal is incubating an empire of startups

Colossal Biosciences claims to have brought back the dire wolf, and is now hard at work on its quest to resurrect several other species, including the woolly mammoth and the moa, a...

Read source
genengnews.com /1 month ago

10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership

Traditionally focused on research tools for academic, government, and industry customers, 10x has moved this year to launch clinical collaborations with top-tier institutions—the m...

Read source
rna-seqblog.com /1 day ago

HeartBeat.bio and Cubase Bio Partner to Advance 3D Spatial Transcriptomics for Cardiovascular Drug Discovery

HeartBeat.bio and Cubase Bio are combining cardiac organoids with 3D spatial transcriptomics and RNA sequencing to study...

Read source
newswire.com /1 day ago

eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT

Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027

Read source
newswire.com /3 weeks ago

Bioz and InvivoGen Elevate Scientific Discovery with an Expanded Digital Research Experience

Read source
newswire.com /1 month ago

JASCO and Bioz Celebrate a Longstanding Partnership Advancing Scientific Product Discovery

Read source
genengnews.com /5 days ago

Watchmaker Genomics Boosts Manufacturing Capacity with Major Boulder Campus Expansion

The Flatiron Park facility in Colorado will serve as the Watchmaker Boulder Manufacturing Center of Excellence for reagent manufacturing and will house the company’s manufacturing,...

Read source
biopharmadive.com /1 month ago

With $263M, LifeMine unearths a new drug for organ transplants

Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...

Read source
newswire.com /1 month ago

Exousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment

Strategic Financing to Accelerate Exosome Pipeline Expansion, International Joint Ventures, and Scale-Up of NexTel Medical (MAJI)

Read source
nanowerk.com /4 weeks ago

World's first oral microbiome-based nanomedicine to supercharge anti-cancer immunity

Engineered a DHB prodrug-based oral nano-emulsion with enhanced bioavailability, dramatically improving the efficacy of immune checkpoint blockade therapy.

Read source
genengnews.com /1 month ago

Celonic and Leukocare Collaborate to Support Complex Biologics and Advanced Drug Development

The collaboration brings together Celonic’s expertise in cell line development, drug substance process development, intensified bioprocessing, and GMP manufacturing with Leukocare’...

Read source
lifespan.io /3 weeks ago

GenBio Launches a “Virtual Cell” AI Model

This AI startup, which lists Nobel laureate David Baker among its co-founders, has announced a “world model” of a cell that can simulate both its natural state and […]

Read source
pharmexec.com /1 day ago

<![CDATA[Moonwalk Biosciences Closes $70 Million Series B ]]>

Read source
fiercebiotech.com /1 month ago

Acrosian debuts as AI-focused biometrics CRO

The founders of contract research organization Quartesian have reunited to form Acrosian, a CRO designed to be purpose-built for the AI era.

Read source
rna-seqblog.com /1 month ago

Novogene Europe Expands Single-cell Sequencing Capability at Cambridge Omics Centre

Expanded RNA sequencing services at Novogene Europe bring advanced single-cell transcriptomics, bioinformatics, and multiomics support closer to UK researchers studying complex bio...

Read source
asianscientist.com /1 month ago

The New Economics of Population Genomics

Twist Bioscience’s integrated ecosystem of next-generation sequencing tools that drive up throughput and lower cost is powering a new era of population genetics research.

Read source
quantumcomputingreport.com /1 month ago

High Q Technologies Partners with Creative Biostructure to Scale Quantum-Enabled EPR Protein Mapping

Waterloo, Ontario-based startup High Q Technologies has announced a global commercial partnership with Creative Biostructure, a Shirley, New York-based contract research organizati...

Read source
prweb.com /4 weeks ago

Molecular Devices and HeartBeat.bio Help Researchers Identify Cardiac Safety Risks Earlier with New Human Cardiac Organo...

New 3D Readyâ„¢ Cardioid Supplement Kits combine advanced cardiac organoid biology and automated workflows to help researchers generate more reproducible, scalable cardiac models f...

Read source
genengnews.com /2 weeks ago

DeepCyte Launches Single-Cell Metabolomic Reference Atlas of Drug Toxicity Mechanisms

Rather than generating new wet-lab data for every compound, DeepCyte trains a foundation model that is capable of predicting toxicity mechanisms for compounds that it has never mea...

Read source
fiercebiotech.com /1 month ago

Icon inks Anthropic partnership to deploy Claude into clinical trials

Contract research organization Icon announced a multi-year collaboration with Anthropic this week to bring Claude’s AI capabilities to clinical trials.

Read source
genengnews.com /2 weeks ago

StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too

Because intismeran autogene is a personalized cancer therapy made for each patient based on the individual genetic mutations of their tumors, the Merck-Moderna stock surge extended...

Read source
fiercebiotech.com /1 week ago

Genentech doubles down on ADC-resistant cancers with $1B DualityBio pact

Roche’s Genentech is paying DualityBio $45 million upfront for rights to antibody-drug conjugates (ADCs) designed for the growing pool of patients who progress after treatment with...

Read source
genengnews.com /1 day ago

Clean Cells Broadens Viral Safety Testing Portfolio with NGS

The expanded next-generation sequencing offering from Clean Cells now covers GMP-compliant viral safety testing for viral vectors and recombinant preparations, building on existing...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Colossal Biosciences

feeds.feedburner.com

Recent coverage from public sources
Public source

quantumcomputingreport.com

Recent coverage from public sources
Public source

techcrunch.com

Recent coverage from public sources
Public source

asianscientist.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source

fastcompany.com

Recent coverage from public sources
Public source